NCT05997914Enrolling by invitation
Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation Randomized Trial (STORY-AF Trial)
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The overall goal of this study is to evaluate the effectiveness of a previously developed storytelling intervention on anticoagulation (AC) initiation/persistence in African American and Black patients with atrial fibrillation/flutter. The investigators hope to gain knowledge that may help treat atrial fibrillation or flutter and lower stroke and adverse cardiovascular event risks for African American and Black patients by increasing the use of blood thinning medications known as anticoagulants.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 25 Jul 2023
- Start date
- 24 Jun 2024
- Primary completion date
- Nov 2026
- Lead sponsor
- University of Massachusetts, Worcester
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT05997914
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 24 Jun 2024 to the primary completion date, Nov 2026
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient without a visit with a primary care provider, cardiovascular medicine specialist, or ambulatory care provider in the previous one year
Other illness
- Patients with left atrial appendage surgery or device, hospice status, ongoing bleeding, and intracranial bleeding in intralobar territory
Age
- Non-African American and other non-Black patients under the age of 18 patients without an ICD-10 diagnostic code consistent with AF or atrial fibrillation or atrial flutter
Other
- Patient who is pregnant or a prisoner.
Who the study is looking for
- African-American patients aged 18 or older with elevated stroke risk (CHA2DS2-VASc ≥2 for men and ≥3 for women) who are not currently on anticoagulation (AC) but for whom a cardiology provider or primary care provider at the two study sites recommended AC recently
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Medical School Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
| Luis Ortega Paz Coordinator of this site? Confirm its status | Jacksonville | United States | Unknown status |
| Decentralized Coordinator of this site? Confirm its status | Worcester | United States | Unknown status |
| UMass Chan Medical School Coordinator of this site? Confirm its status | Worcester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.